Skip to lesson
OncoGuideeducationDiana’s wiki
THE EDUCATION LIBRARY

Costimulation

In one sentence

Costimulation is support from additional receptor interactions that helps shape a T cell’s response to antigen recognition.

The intuition

Recognizing the right task is not the same as receiving support to undertake it. A T cell encounters a target through its receptor, while additional interactions help determine its response. Think of a task request and a supporting conversation. The analogy is limited: there is no single permission button, and many signals cooperate over time.

How it works

A T-cell receptor (TCR) recognizes a particular peptide–human leukocyte antigen (HLA) combination. This supplies antigen specificity. Costimulatory receptors engage additional partners that alter activation, survival, division or differentiation. They do not substitute a different antigen into the receptor's recognition rule.

A well-studied example is CD28, a receptor on many T cells. Its partners CD80 and CD86, sometimes called B7 molecules, can be displayed by antigen-presenting cells. Linsley and colleagues demonstrated CD28-dependent support for proliferation and interleukin-2 responses in controlled experiments. Interleukin 2 is a cytokine, a signaling protein.

The three-signal model of priming groups TCR recognition as signal one, costimulation as signal two and differentiation signals as signal three. This is a useful learning framework. Real responses depend on signal strength, duration, cell state, location and inhibitory interactions. Costimulation has several molecular forms; CD28 is a central example rather than the whole category.

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) can compete for the same CD80/CD86 partners and remove them from presenting cells. That makes the availability of a supporting ligand part of immune regulation. CD28 and CTLA-4 do different jobs even though their binding partners overlap. The checkpoint concept explains the broader distinction.

Costimulation also matters after initial priming. Kamphorst and colleagues found that rescue by programmed cell death protein 1, or PD-1, blockade depended on CD28 in their experimental systems. Their related observations in lung-cancer patients help connect the mechanism to human responses. They do not establish a stand-alone CD28 test that selects treatment for every patient.

Antigen recognition+ supporting interactions+ inhibitory context IntegratedT-cell response Measure activationand function

Recognition chooses the target. Supporting interactions and cell context shape the response.

Why it matters in cancer

A cancer cell displaying a target may still be poor at priming a naive T cell. Dendritic cells can connect display with a suitable support context. This helps explain why tumor recognition and initial immune teaching are different jobs.

Engineered receptors can include intracellular supporting domains, as described in chimeric antigen receptor (CAR) anatomy. That design choice changes signaling architecture. It does not establish useful persistence, safety or clinical benefit without tests of the actual product and setting.

Common confusions

  • Costimulation does not prove that the recognized antigen is tumor-specific.
  • “Signal two” is a teaching category, not one universal molecule or threshold.
  • Blocking an inhibitory receptor and adding a costimulatory signal are different interventions.
  • A stronger response in a dish does not show an acceptable safety window in the body.

How it is measured

A controlled cell experiment can compare the same recognition stimulus with and without a supporting ligand or pathway perturbation. Outputs may include division, cytokine production or killing. Include recognition-only controls and relevant inhibitory conditions. Marker abundance alone cannot show which interaction caused the response.

Try it

Two fictional presenting cells show the same peptide–HLA pair. One also provides CD80/CD86; the other does not. Must responding T cells recognize different antigens?

Answer: No. Antigen recognition can be the same while response support differs. You would measure the response under matched conditions rather than infer it from the displayed peptide alone.

Sources and scope

Source check: October 9, 2026. Supporting interactions and experimental interpretation, not a treatment-selection assay. Expert and learner review remain pending.

Used in